Literature DB >> 19816009

Arsenic trioxide in a hemodialytic patient with acute promyelocytic leukemia.

Yuko Yamamoto1, Makoto Sasaki, Kazuo Oshimi, Koichi Sugimoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19816009     DOI： 10.1159/000243724

Source DB:  PubMed          Journal:  Acta Haematol        ISSN： 0001-5792            Impact factor:   2.195


× No keyword cloud information.
  9 in total

1.  Effect of continuous venovenous haemodialysis on outcome and pharmacokinetics of arsenic species in a patient with acute promyelocytic leukaemia and acute kidney injury.

Authors:  Chunlu Gao; Shengjin Fan; Thomas H Hostetter; Wenjing Wang; Jing Li; Meihua Guo; Jin Zhou; Xin Hai
Journal:  Br J Clin Pharmacol       Date:  2019-02-14       Impact factor: 4.335

2.  The association of urine arsenic with prevalent and incident chronic kidney disease: evidence from the Strong Heart Study.

Authors:  Laura Y Zheng; Jason G Umans; Fawn Yeh; Kevin A Francesconi; Walter Goessler; Ellen K Silbergeld; Karen Bandeen-Roche; Eliseo Guallar; Barbara V Howard; Virginia M Weaver; Ana Navas-Acien
Journal:  Epidemiology       Date:  2015-07       Impact factor: 4.822

3.  Successful treatment of acute promyelocytic leukemia in a patient on hemodialysis.

Authors:  Yoshiki Tsuchiya; Yoshifumi Ubara; Tatsuya Suwabe; Junichi Hoshino; Keiichi Sumida; Rikako Hiramatsu; Eiko Hasegawa; Masayuki Yamanouchi; Noriko Hayami; Yuji Marui; Naoki Sawa; Fumi Takemoto; Kenmei Takaichi
Journal:  Clin Exp Nephrol       Date:  2011-02-05       Impact factor: 2.801

4.  Tetramethylpyrazine (TMP) protects against sodium arsenite-induced nephrotoxicity by suppressing ROS production, mitochondrial dysfunction, pro-inflammatory signaling pathways and programed cell death.

Authors:  Xuezhong Gong; Vladimir N Ivanov; Mercy M Davidson; Tom K Hei
Journal:  Arch Toxicol       Date:  2014-06-25       Impact factor: 5.153

5.  Feasibility of oral arsenic trioxide treatment for acute promyelocytic leukemia during hemodialysis.

Authors:  Wing-Yan Au; Bonnie M Fong; Sidney Tam; Yok-Lam Kwong
Journal:  Ann Hematol       Date:  2012-09-30       Impact factor: 3.673

6.  Successful treatment of relapsed acute promyelocytic leukemia with arsenic trioxide in a hemodialysis-dependent patient: A case report.

Authors:  Hee Jeong Lee; Sang-Gon Park
Journal:  World J Clin Cases       Date:  2020-11-06       Impact factor: 1.337

7.  Successful treatment of acute promyelocytic leukemia in a patient undergoing hemodialysis with arsenic trioxide.

Authors:  Akiko Hashimoto; Yasuhiro Tanaka; Isaku Shinzato
Journal:  Clin Case Rep       Date:  2021-07-23

8.  Relapsed acute promyelocytic leukemia in a hemodialysis-dependent patient treated with arsenic trioxide: a case report.

Authors:  Gregory S Emmons; Richard H Steingart; James A Stewart; Wilson C Mertens
Journal:  J Med Case Rep       Date:  2012-10-18

9.  Successful treatment of acute promyelocytic leukemia in a patient under hemodialysis with arsenic trioxide.

Authors:  Akiko Hashimoto; Yasuhiro Tanaka; Takayuki Ishikawa; Isaku Shinzato
Journal:  Clin Case Rep       Date:  2021-07-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.